Introduction Spondyloarthritis is characterised by inflammation, extensive angiogenesis and pathological osteogenesis. Transmembrane (tm) TNF transgenic (tg) mice 1 that overexpress tmTNF exhibit features of SpA, including chronic inflammation and pathological osteogenesis. tmTNF ligation to TNF receptor 2 in endothelial cells (ECs) can induce signal transduction pathways, that may promote these processes. Of note, angiogenesis and osteogenesis are coupled by EC differentiation towards a type H (CD31 hi endomucin hi ) phenotype.
2
Objectives To investigate the link between pathological angiogenesis and osteogenesis in tmTNF tg mice and the potential contribution of noncanonical NF-kB signalling in ECs to this process and infiltration of immune cells into the bone marrow (BM).
Methods Vertebrae and ankles from 6 and 12 weeks and 8 months old tmTNF tg mice or sex-matched non-tg littermates (n=18) were prepared by cutting 60 mm thick cryosections for confocal imaging.
Results tmTNF tg mice exhibited ectopic osteogenesis which was not observed in non-tg littermates. Immunostainings showed that type H vessels are in the vicinity of the ectopic osteogenesis and osterix + osteoprogenitors. At six weeks of age, osterix + cells are located throughout the ectopic lesion, while at eight months, osterix + cells are only present at the border of the lesion. Furthermore, there is increased osteogenesis and a different vessel architecture within the vertebrae of tmTNF tg mice compared to non-tg littermates that progresses with age. Non-tg littermate vertebrae only have physiological osteogenesis, which is in the metaphysis and periosteum. In addition, tmTNF tg mice also exhibit altered bone marrow (BM) architecture containing extensive lymphoid aggregates, which predominantly consisted of B220 + B cells. Conclusions tmTNF overexpression in mice leads to development of type H vessels associated with ectopic osteogenesis. In addition, extensive lymphoid aggregates develop in the BM. Current studies are aimed at identification of signalling pathways in ECs that contribute to these processes.
Introduction Fibrosis is a key process in Systemic Sclerosis, a devastating disease that is not well understood. The role of epigenetic disease mechanisms is increasingly explored. DOT1L, the unique H3K79-methyltransferase, methylates histone 3 at the Lysine residue at position 79, and regulates gene expression. Inhibition of DOT1L has cell-type specific effects on Wnt-signalling, a pathway suggested to play an important role in fibrosis. Objectives To study the role of DOT1L in fibrosis. Methods Primary cell cultures of fibroblasts, isolated from healthy human skin and treated with DOT1L-inhibitor EPZ-5676 or vehicle for 14 days, were stimulated with TGFb 5 ng/ml after starvation. Smooth muscle alpha 2 actin (ACTA2) gene expression was measured by RT-qPCR. Efficiency of DOT1L-inhibition was analysed with Western Blot for dimethylated H3K79. Picrosirius Red staining measured collagen I and III deposition. Proliferation was analysed with 5-Bromo-2'-deoxy-uridine (BrdU) labelling. 7-9 week old Col1a2; Cre-ERT 2 ; DOT1l fl/fl mice were injected intraperitoneally with tamoxifen (1 mg/day,5 days) to induce a fibroblastspecific DOT1L knockout. Bleomycin (0.1 mg) or vehicle was injected subcutaneously (5 days/week, 4 weeks). Injected skin was analysed by OH-prolin assay for collagen content, and by histology for dermal thickness measurement. Results The DOT1L-inhibitor EPZ-5676 reduced H3K79 dimethylation in all samples. TGFb increased expression of ACTA2
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